Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate in adults with ADHD and substance use disorder
NL-OMON30648Active, not recruiting
- Sponsor
- Trimbos Institute
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), substance use disorder (SUD), alcohol dependence and 1 more, sponsored by Trimbos Institute. Primary endpoint: ADHD symptomatology. Started Mar 2008; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)substance use disorder (SUD)alcohol dependencecocaine use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON30648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30648.